#United States #mental health #San Francisco #Advanced Treatments #Everbright Health

Everbright Health: A New Era of Mental Health Care

In a significant development in the mental health sector, Everbright Health has officially launched with a commendable $7 million seed investment aimed at transforming the way mental health care is delivered. With partnerships already established with 75 providers across seven different markets, Everbright is set to make a considerable impact on patients struggling with mental health issues.

According to statistics from the National Institute of Health, approximately 60 million individuals in the United States are coping with some form of mental illness, with more than 15 million classified as experiencing serious mental illness (SMI). Traditional mental health care has often centered around medications and talk therapy; however, reports suggest that nearly half of those impacted do not see improvements with these standard methods.

Recognizing the urgent need for comprehensive mental health solutions, Everbright Health aims to bridge this gap by supporting mental health professionals—including psychiatrists, psychologists, and therapists—in providing an integrated approach to their patients' care. This approach combines standard treatments with advanced therapies, enhancing personalized care to optimize recovery rates for even the most challenging cases.

Ben Kuhn, Co-founder and CEO of Everbright Health, emphasized the need for innovation in mental health care, stating, “Mental health care has made real progress in expanding access to therapy and medications, but for millions of people, they need more. We're building a future where every mental health provider can deliver a full spectrum of care, including advanced interventions that many patients need to get better.”

The company is primarily focusing on enhancing access to Transcranial Magnetic Stimulation (TMS) and SPRAVATO®, which are proven advanced treatments for depressive disorders and other serious conditions. Although these therapies are FDA-approved and have shown effectiveness—reportedly up to twice as effective as traditional treatments—more than 90% of eligible patients have not had access to these innovations. The reason is often due to a lack of infrastructure among mental health providers to effectively administer these treatments.

Everbright Health provides a comprehensive, end-to-end platform that equips mental health providers with everything needed to incorporate TMS, SPRAVATO®, and other advanced interventions as essential components of their service lines. This platform includes:

• - Clinical Infrastructure: Provision of specialized equipment and training for staff to deliver these advanced therapies.
• - Tech Platform: Utilization of AI solutions for identifying eligible patients, enhancing patient engagement, and streamlining complex prior authorizations.
• - Operational Management: Complete oversight of eligibility assessments, enrollment processes, treatment delivery, billing, and compliance workflows.

Richard Connell, CEO of Oria Health, a mental health practice in Central Texas, shared insights on how Everbright has transformed their service offerings. He remarked, “Everbright made it possible for us to offer treatments we had long known about but weren't equipped to deliver. They bring a turnkey model that fits into our existing practice, so our patients get access to more treatment options and a truly integrated care experience.”

The launch of Everbright Health was facilitated by W Health Ventures, which provided the $7 million seed funding. This venture capital firm, along with Sanos Capital, is dedicated to developing innovative healthcare solutions.

Dr. Pankaj Jethwani, Managing Partner at W Health Ventures, conveyed their optimism about the potential for technology-driven healthcare management services, stating, “We’re bullish on tech-enabled, asset-light management service organizations. Advanced psychiatric interventions are on the cusp of becoming mainstream care. With remarkable outcomes, we believe they are poised to have their own ‘GLP-1’ moment for market adoption.”

Overall, Everbright Health represents a crucial advancement in mental healthcare, promising better outcomes for patients, expansion opportunities for providers, and a reduction in costs for payors. As the company continues to develop, it is positioned to address the needs of the millions of people suffering from treatment-resistant mental health conditions who require more from their mental health care.

For more information about Everbright Health, visit their website at www.everbrighthealth.com.